These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28833001)

  • 1. Dermoscopy of borderline tuberculoid leprosy.
    Ankad BS; Sakhare PS
    Int J Dermatol; 2018 Jan; 57(1):74-76. PubMed ID: 28833001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatoscopy in leprosy and its correlation with clinical spectrum and histopathology: a prospective observational study.
    Vinay K; Kamat D; Chatterjee D; Narang T; Dogra S
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1947-1951. PubMed ID: 31004456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline tuberculoid leprosy with scrofuloderma: an uncommon association.
    Ghunawat S; Bansal S; Sahoo B; Garg VK
    Indian J Dermatol Venereol Leprol; 2014; 80(4):381. PubMed ID: 25035384
    [No Abstract]   [Full Text] [Related]  

  • 4. S-100 as a useful auxiliary diagnostic aid in tuberculoid leprosy.
    Gupta SK; Nigam S; Mandal AK; Kumar V
    J Cutan Pathol; 2006 Jul; 33(7):482-6. PubMed ID: 16872470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Dermoscopic and Histopathologic Patterns in Leprosy - A Pilot Study.
    Chopra A; Mitra D; Agarwal R; Saraswat N; Talukdar K; Solanki A
    Indian Dermatol Online J; 2019; 10(6):663-668. PubMed ID: 31807445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermoscopy in Leprosy: A Clinical and Histopathological Correlation Study.
    Mohta A; Jain SK; Agrawal A; Kushwaha RK; Sharma P; Sethia K; Jain M
    Dermatol Pract Concept; 2021 Mar; 11(2):e2021032. PubMed ID: 33954015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and indeterminate cases using the mouse foot pad technique--a study of 209 cases.
    Wakade AV; Shetty VP
    Lepr Rev; 2006 Dec; 77(4):366-70. PubMed ID: 17343223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of borderline tuberculoid leprosy and tuberculosis: A case report and review of the literature].
    Rousset L; Sokal A; Vignon-Pennamen MD; Pagis V; Rybojad M; Lecorche E; Mougari F; Bagot M; Bouaziz JD; Jachiet M
    Ann Dermatol Venereol; 2020 Dec; 147(12):886-891. PubMed ID: 33127165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms.
    Lastoria LC; Opromolla DV; Fleury RN; Habermann F; Curi PR
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):190-200. PubMed ID: 9728451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borderline tuberculoid (BT) leprosy confined to a tattoo.
    Sehgal VN; Jain S; Bhattacharya SN; Chouhan S
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):323-5. PubMed ID: 2071992
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathologic changes in a tibial nerve with surviving M. leprae in a healed tuberculoid leprosy patient.
    Job CK; Baskaran B; Jayakumar J; Aschhoff M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):90-4. PubMed ID: 9207758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyneuritic leprosy changing into borderline tuberculoid (BT).
    Shenoi SD; Padhee A
    Indian J Lepr; 1990; 62(3):363-4. PubMed ID: 2262723
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermoscopic features of clofazimine-induced pigmentation in a borderline tuberculoid leprosy plaque.
    Behera B; Palit A; Sethy M; Nayak AK; Dash S; Ayyanar P
    Indian J Dermatol Venereol Leprol; 2021; 88(1):85-87. PubMed ID: 34491673
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune status of subsided cases of tuberculoid (TT) and borderline tuberculoid (BT) leprosy.
    Mackay IG; Sengupta U; Ghei SK; Sinha S; Ramu G
    Lepr India; 1982 Oct; 54(4):653-63. PubMed ID: 6763967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
    Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Tap sign" in tuberculoid and borderline tuberculoid leprosy.
    Kumarasinghe SP; Kumarasinghe MP; Amarasinghe UT
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):291-5. PubMed ID: 15485286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.